BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11869948)

  • 21. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of CD95 upregulation does not render chronic lymphocytic leukemia B-cells susceptible to CD95-mediated apoptosis.
    Romano C; De Fanis U; Sellitto A; Chiurazzi F; Guastafierro S; Giunta R; Tirelli A; Rotoli B; Lucivero G
    Immunol Lett; 2005 Feb; 97(1):131-9. PubMed ID: 15626485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A further characterization of B-CLL lymphocytes: phenotypic and functional studies.
    Merle-Béral H
    Nouv Rev Fr Hematol (1978); 1990; 32(5):319-21. PubMed ID: 2099403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic lymphocytic leukemia. II. Differentiation of various forms of chronic lymphocytic leukemia by cytological and immunological indicators].
    Popova L; Apostolov P; Vlaĭkova S; Stamenova L
    Vutr Boles; 1988; 27(3):76-80. PubMed ID: 3264645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia.
    Rossmann ED; Lenkei R; Lundin J; Mellstedt H; Osterborg A
    Cytometry B Clin Cytom; 2007 Nov; 72(6):450-7. PubMed ID: 17565749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD23 and chronic lymphocytic leukemia.
    Sarfati M
    Blood Cells; 1993; 19(3):591-6; discussion 597-9. PubMed ID: 8018941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia.
    Smilevska T; Stamatopoulos K; Samara M; Belessi C; Tsompanakou A; Paterakis G; Stavroyianni N; Athanasiadou I; Chiotoglou I; Hadzidimitriou A; Athanasiadou A; Douka V; Saloum R; Laoutaris N; Anagnostopoulos A; Fassas A; Stathakis N; Kollia P
    Leuk Res; 2006 Feb; 30(2):183-9. PubMed ID: 16054692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
    Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
    Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
    Junevik K; Werlenius O; Hasselblom S; Jacobsson S; Nilsson-Ehle H; Andersson PO
    Ann Hematol; 2007 Feb; 86(2):89-94. PubMed ID: 17043777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of interleukin-2 on CD95 (Fas/APO-1) expression in fresh chronic lymphocytic leukaemia and mantle cell lymphoma cells: relationship to ex vivo chemoresponse.
    Bosanquet AG; Bell PB; Rooney N
    Anticancer Res; 1999; 19(6B):5329-34. PubMed ID: 10697557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of HLA-DR expression in a patient with B-chronic lymphocytic leukemia.
    Vartholomatos G; Kapsali E; Dokou E; Bourantas KL
    J Exp Clin Cancer Res; 2001 Jun; 20(2):305-6. PubMed ID: 11484993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Kampalath B; Barcos MP; Stewart C
    Am J Clin Pathol; 2003 Jun; 119(6):824-32. PubMed ID: 12817430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B; Wooldridge JE; Blackwell SE; Taylor CM; Griffith TS; Link BK; Weiner GJ
    J Leukoc Biol; 2005 Mar; 77(3):378-87. PubMed ID: 15582984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant phenotypic expression of the T-cell-associated antigen CD8 on B-cell chronic lymphocytic leukemia cells.
    Stagno F; Triolo A; Del Fabro V; Berretta S; Parrinello NL; Fargione G; Di Raimondo F
    Lab Hematol; 2009; 15(1):1-3. PubMed ID: 19273392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells.
    Chiorazzi N
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):399-413. PubMed ID: 17707829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response.
    Orsini E; Guarini A; Chiaretti S; Mauro FR; Foa R
    Cancer Res; 2003 Aug; 63(15):4497-506. PubMed ID: 12907623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.